In letter, senators say recent staff firings could affect drug and device approval, food safety and public health threats.
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.
Extended producer responsibility (EPR) laws are relatively new – the first were signed into law in 2021 and 2022 – and are ...